Cardiovascular Risks in Obesity

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2003 Jan 2

PMID 12508955

Citations 3

Authors

E C Uchegbu

P G Kopelman

Affiliations

Soon will be listed here.

Citing Articles

MicroRNA-196 Regulates HOX Gene Expression in Human Gluteal Adipose Tissue.

Divoux A, Xie H, Li J, Karastergiou K, Perera R, Chang R Obesity (Silver Spring). 2017; 25(8):1375-1383.

PMID: 28649807 PMC: 5551414. DOI: 10.1002/oby.21896.

Novel molecular aspects of ghrelin and leptin in the control of adipobiology and the cardiovascular system.

Rodriguez A Obes Facts. 2014; 7(2):82-95.

PMID: 24685565 PMC: 5644879. DOI: 10.1159/000360837.

Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation.

Zanni M, Stanley T, Makimura H, Chen C, Grinspoon S Clin Endocrinol (Oxf). 2009; 73(1):48-54.

PMID: 19878508 PMC: 2891313. DOI: 10.1111/j.1365-2265.2009.03741.x.

References

Woodward M, Lowe G, Rumley A, Tunstall-Pedoe H, Philippou H, Lane D . Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 1997; 97(4):785-97. DOI: 10.1046/j.1365-2141.1997.1232935.x. View

Sowers J, Whitfield L, Catania R, Stern N, Tuck M, Dornfeld L . Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab. 1982; 54(6):1181-6. DOI: 10.1210/jcem-54-6-1181. View

Eckel R, Krauss R . American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation. 1998; 97(21):2099-100. DOI: 10.1161/01.cir.97.21.2099. View

Hubert H, Feinleib M, MCNAMARA P, CASTELLI W . Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5):968-77. DOI: 10.1161/01.cir.67.5.968. View

Lauer M, Anderson K, Kannel W, Levy D . The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA. 1991; 266(2):231-6. View

Chan J, Rimm E, Colditz G, Stampfer M, Willett W . Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994; 17(9):961-9. DOI: 10.2337/diacare.17.9.961. View

Dervan J, Ilercil A, Kane P, Anagnostopoulos C . Fatty infiltration: another restrictive cardiomyopathic pattern. Cathet Cardiovasc Diagn. 1991; 22(3):184-9. DOI: 10.1002/ccd.1810220307. View

Festa A, DAgostino Jr R, Williams K, Karter A, Mayer-Davis E, Tracy R . The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001; 25(10):1407-15. DOI: 10.1038/sj.ijo.0801792. View

Lavie C, Messerli F . Cardiovascular adaptation to obesity and hypertension. Chest. 1986; 90(2):275-9. DOI: 10.1378/chest.90.2.275. View

10.

Austin M, King M, Vranizan K, Krauss R . Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990; 82(2):495-506. DOI: 10.1161/01.cir.82.2.495. View

11.

Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L . Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed). 1984; 289(6454):1257-61. PMC: 1443498. DOI: 10.1136/bmj.289.6454.1257. View

12.

Sharma A, Moeller T, Engeli S . [Hypertension in obesity: its epidemiology, physiopathology and treatment efforts]. Dtsch Med Wochenschr. 1999; 124(45):1337-41. DOI: 10.1055/s-2007-1024539. View

13.

Vollenweider P, Tappy L, Randin D, Schneiter P, Jequier E, NICOD P . Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest. 1993; 92(1):147-54. PMC: 293552. DOI: 10.1172/JCI116542. View

14.

Colditz G, Willett W, Rotnitzky A, Manson J . Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995; 122(7):481-6. DOI: 10.7326/0003-4819-122-7-199504010-00001. View

15.

Kirchgessner T, Uysal K, Wiesbrock S, Marino M, Hotamisligil G . Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest. 1998; 100(11):2777-82. PMC: 508482. DOI: 10.1172/JCI119824. View

16.

Juhan-Vague I, Pyke S, Alessi M, Jespersen J, Haverkate F, Thompson S . Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation. 1996; 94(9):2057-63. DOI: 10.1161/01.cir.94.9.2057. View

17.

Van Gaal L, Wauters M, De Leeuw I . The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord. 1997; 21 Suppl 1:S5-9. View

18.

Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E . Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab. 1986; 62(6):1302-4. DOI: 10.1210/jcem-62-6-1302. View

19.

de Divitiis O, Fazio S, Petitto M, Maddalena G, Contaldo F, Mancini M . Obesity and cardiac function. Circulation. 1981; 64(3):477-82. DOI: 10.1161/01.cir.64.3.477. View

20.

Yang W, Lee W, Funahashi T, Tanaka S, Matsuzawa Y, Chao C . Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001; 86(8):3815-9. DOI: 10.1210/jcem.86.8.7741. View